Outlook Therapeutics (OTLK) Selling, General & Administrative (2015 - 2026)
Outlook Therapeutics (OTLK) Selling, General & Administrative (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 347.92 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -196.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 247.47 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 161.89 Mn |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | 7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.50 Mn |
| Dec 31, 2025 | 8.61 Mn |
| Sep 30, 2025 | 10.33 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 7.98 Mn |
| Dec 31, 2024 | 11.95 Mn |
| Sep 30, 2024 | 10.35 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 6.29 Mn |
| Dec 31, 2022 | 5.83 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 3.50 Mn |
| Jun 30, 2021 | 2.93 Mn |